BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

openQ Leads the Way in Compliant Investigator Sponsored Trial Solutions with Introduction of Expert Screening  to OpenIIS


1/12/2011 10:34:39 AM

Charlottesville, VA – January 12, 2010 – OpenQ, the industry leader in critical compliance solutions for  life science companies has become the first company to meet an urgent need for companies looking to  maintain a compliant Investigator Initiated Studies (IIS) or Investigator Sponsored Trials (IST) program by  integrating their Expert Screening data into their OpenIIS offering.  The new capability aids companies by  delivering up-to-date clinical and compliance profiles of investigators requesting company funding.     Expert Screening offers a comprehensive search of extensive resources to verify clinical experience,  licensing and reveal censures or warnings issued by FDA or other federal authorities and state boards.   The Expert Screening solution is currently used by some of the world’s largest Pharmaceutical  companies to verify their KOLs’ professional backgrounds.

“Recent media scrutiny into the backgrounds of Investigators and other HCPs has created a critical  challenge for Life Sciences companies looking to encourage clinical studies and maintain compliance.   Finding out that a funded Investigator has received an FDA warning would be a difficult surprise.  Even  worse would be finding out in the news media,” said Jim Zuffoletti, President of OpenQ.   “We  developed Expert Screening and integrated into OpenIIS, our leading offering for managing IIS programs,  to make it simple and economical for companies to avoid this issue and know that the investigators they  collaborate with possess the clinical experience and the discipline-free records the industry values.”

  About OpenQ:

  Based in Charlottesville, Virginia, OpenQ helps Life Sciences companies manage compliant business  processes in their Marketing and Medical Affairs organizations. OpenQ offers award-winning solutions  for compliant business processes focused on KOL Management, Medical Affairs Programs, Study  Management & Grant Funding, and Speaker Programs. OpenQ’s solutions currently support compliance  initiatives at 8 of the Top 10 Pharmaceutical and 3 of the Top 5 Medical Device Companies. For more  information, visit www.openq.com.

  To view OpenQ’s recent web seminar on managing compliant Investigator Sponsored Trials programs  please got to - http://www.openq.com/IISWebinar/



Read at BioSpace.com

OpenQ
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES